Amgen Inc (AMGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2018 | 12-2017 | 12-2016 | 12-2015 | 12-2014 | |
| Sales | 23,747,000 | 22,849,000 | 22,991,000 | 21,662,000 | 20,063,000 |
| Cost of Goods | 4,101,000 | 4,069,000 | 4,162,000 | 4,227,000 | 4,422,000 |
| Gross Profit | 19,646,000 | 18,780,000 | 18,829,000 | 17,435,000 | 15,641,000 |
| Operating Expenses | 9,383,000 | 8,807,000 | 9,035,000 | 8,965,000 | 9,450,000 |
| Operating Income | 10,263,000 | 9,973,000 | 9,794,000 | 8,470,000 | 6,191,000 |
| Interest Expense | 1,392,000 | 1,304,000 | 1,260,000 | 1,095,000 | 1,071,000 |
| Other Income | 674,000 | 928,000 | 629,000 | 603,000 | 465,000 |
| Pre-tax Income | 9,545,000 | 9,597,000 | 9,163,000 | 7,978,000 | 5,585,000 |
| Income Tax | 1,151,000 | 7,618,000 | 1,441,000 | 1,039,000 | 427,000 |
| Net Income Continuous | 8,394,000 | 1,979,000 | 7,722,000 | 6,939,000 | 5,158,000 |
| Net Income | $8,394,000 | $1,979,000 | $7,722,000 | $6,939,000 | $5,158,000 |
| EPS Basic Total Ops | 12.70 | 2.71 | 10.32 | 9.15 | 6.80 |
| EPS Basic Continuous Ops | 12.70 | 2.71 | 10.32 | 9.15 | 6.80 |
| EPS Diluted Total Ops | 12.62 | 2.69 | 10.24 | 9.06 | 6.70 |
| EPS Diluted Continuous Ops | 12.62 | 2.69 | 10.24 | 9.06 | 6.70 |
| EPS Diluted Before Non-Recurring Items | 14.40 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $12,209,000 | $11,928,000 | $11,899,000 | $10,578,000 | $8,283,000 |